![The ICR on Twitter: "We were delighted to welcome @JonAshworth (MP & Shadow Health Secretary) to visit us today with @CRUK_Policy to meet Professor Kevin Harrington and team. Jon saw some of The ICR on Twitter: "We were delighted to welcome @JonAshworth (MP & Shadow Health Secretary) to visit us today with @CRUK_Policy to meet Professor Kevin Harrington and team. Jon saw some of](https://pbs.twimg.com/media/DtFiul6XgAAgVaL.jpg:large)
The ICR on Twitter: "We were delighted to welcome @JonAshworth (MP & Shadow Health Secretary) to visit us today with @CRUK_Policy to meet Professor Kevin Harrington and team. Jon saw some of
![Radiotherapy supercharges cancer-targeting viruses to treat deadly skin cancer - The Institute of Cancer Research, London Radiotherapy supercharges cancer-targeting viruses to treat deadly skin cancer - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/default-album/t-vec-infected-melanoma-cells-(green)_kevin-harrington-embed.jpg?sfvrsn=70547b69_2)
Radiotherapy supercharges cancer-targeting viruses to treat deadly skin cancer - The Institute of Cancer Research, London
![Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/researchers/kevin-harrington-appearing-on-bbc-panorama.jpg?sfvrsn=a7226f69_2)
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
![ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/images/default-source/default-album/icr-rmh-clarivate-highly-cited-researchers-202117064fcb659564f3a772ff0000325351.jpg?sfvrsn=8d932b69_0)
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
![The ICR on Twitter: "Today, Prof. Kevin Harrington (ICR/@cancerBRC) will present on a trial of RP2, a first-in-class, enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody as a single agent and combined The ICR on Twitter: "Today, Prof. Kevin Harrington (ICR/@cancerBRC) will present on a trial of RP2, a first-in-class, enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody as a single agent and combined](https://pbs.twimg.com/media/FUeZSb3WYAEpqX9.png)
The ICR on Twitter: "Today, Prof. Kevin Harrington (ICR/@cancerBRC) will present on a trial of RP2, a first-in-class, enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody as a single agent and combined
![The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a](https://pbs.twimg.com/media/FCTe35EX0AAn_Tc.png)
The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a
![The ICR on Twitter: "Watch Professor Kevin Harrington on @BBCLondonNews as he shares more on how a modified version of the herpes virus could offer hope for some people with advanced #Cancer. The ICR on Twitter: "Watch Professor Kevin Harrington on @BBCLondonNews as he shares more on how a modified version of the herpes virus could offer hope for some people with advanced #Cancer.](https://pbs.twimg.com/media/Fd0_KuNaEAEhWJ5.png)
The ICR on Twitter: "Watch Professor Kevin Harrington on @BBCLondonNews as he shares more on how a modified version of the herpes virus could offer hope for some people with advanced #Cancer.
The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR + @royalmarsdenNHS) featured earlier in a @BBCr4today segment on #immunotherapy. In the UK you can still listen to today's live program
![BBC Two - Trust Me, I'm a Doctor, Series 3, Episode 3 - Could viral immunotherapy be a revolution in cancer treatment? BBC Two - Trust Me, I'm a Doctor, Series 3, Episode 3 - Could viral immunotherapy be a revolution in cancer treatment?](https://ichef.bbci.co.uk/images/ic/1920x1080/p02y58py.jpg)
BBC Two - Trust Me, I'm a Doctor, Series 3, Episode 3 - Could viral immunotherapy be a revolution in cancer treatment?
![ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers - The Institute of Cancer Research, London ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/images/default-source/default-album/june-dc---kevin1f0654cb659564f3a772ff0000325351.tmb-0945x532.jpg?sfvrsn=85933069_1)
ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers - The Institute of Cancer Research, London
![The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter](https://pbs.twimg.com/media/DMFIh_3X0AAF17g.jpg:large)
The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter
![High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/default-album/the-icr's-professor-kevin-harrington-at-the-cheltenham-science-festival.jpg?sfvrsn=57f36269_0)
High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London
The Institute of Cancer Research - Professor Kevin Harrington (ICR + Royal Marsden NHS Foundation Trust) responds to today's news of the 2018 Nobel Prize for Physiology or Medicine being awarded to
![The ICR on Twitter: "Professor Kevin Harrington explained the basic principles of using viruses to treat cancer and talked about the cancer-killing virus therapy, T-VEC. Find out more about how viral immunotherapies The ICR on Twitter: "Professor Kevin Harrington explained the basic principles of using viruses to treat cancer and talked about the cancer-killing virus therapy, T-VEC. Find out more about how viral immunotherapies](https://pbs.twimg.com/media/EksuaANXIAAxAzY.jpg)